For manufacturers of drugs, biologics, biosimilars, generics, and medical devices, firms are subject to various statutory and regulatory requirements under FDA regulations governing Good Laboratory Practice (GLP), Good Clinical Practice (GCP) and current Good Manufacturing Practice (cGMP).
To provide safe and effective medical products, it is important for the FDA-regulated industry to accurately understand and apply the applicable regulations and requirements under GLP, GCP, and GMP.
This conference is intended to help FDA-regulated industry and professionals get better familiar with the GLP, GCP and cGMP requirements from practical perspectives.This conference will help firms implement and achieve compliance better with improved awareness.
Dr. David Lim, Ph.D., RAC, ASQ-CQA. Dr. Lim is President and Principal of Regulatory Consulting Firm, Regulatory Doctor (www.RegulatoryDoctor.us). Dr. Lim is a leading industry speaker and has presented and addressed FDA regulatory and compliance matters in various forums and meetings.
Dr. Lim has helped both pharma and medical device industry for regulatory, clinical and compliance matters. Dr. Lim has also advised many firms including, but not limited to risk management firms, venture capital firms, asset management firms, and fund managers to make right investment decisions in view of FDA regulatory and compliance matters.
01:00 PM EST 12:00 PM CST 11:00 AM MST 10:00 AM PST